USD/JPY slides below mid-148.00s, downside potential seems limited
The USD/JPY pair struggles to capitalize on a modest Asian session uptick or find acceptance above the 149.00 mark and
The USD/JPY pair struggles to capitalize on a modest Asian session uptick or find acceptance above the 149.00 mark and
The US Food and Drug Administration (FDA) has approved a subcutaneous formulation of the anti-CD20 antibody ocrelizumab (Ocrevus Zunovo, Genentech)
Manchester City has launched a new fourth shirt for its European campaign, with fans able to bag a pair of
Google News (Australia)Canadian woman charged after $12.3M of meth allegedly found in luggage CTV News…Read More
No posts found.